Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Recruiting Observational

Comparison of Surgical Repair Versus Functional Treatment in Patients With Proximal ACL Tear

NCT06178484 · tracked via the Priya Life Science France tracker
Phase
Observational
Started
2023-12-01
Last updated
2026-08-20

Condition(s) studied

ACL - Anterior Cruciate Ligament Deficiency

Study summary

Isolated ruptures of the anterior cruciate ligament (ACL) can be proximal, distal or occur in the middle of the ACL.

Treatment of patients with proximal lesions should be graded. Functional treatment can be reserved for low-demanding patients in whom the practice level is limited and the risk of progression to a knee functionally unstable less marked. In athletes, the risk of a new sprain must be explained and the patient will choose a functional treatment or a surgical treatment.

Few studies exist in the literature on the superiority of surgical treatment compared to functional treatment. In this context, this study is based on the hypothesis that patients undergoing ACL surgical repair have better functional scores and more intense sport activity than patients with functional treatment.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Patient, male or female, aged ≥ 18 years * Patient with no history of knee surgery except meniscal surgery * Patient whose period is less than 3 months between the date of the accident and the surgery * Patient with an isolated proximal Sherman 1 or 2 ACL tear * Patient with a proximal Sherman 1 or 2 ACL tear associated to a stable meniscal lesion or to an MCL or LCL lesion grade 1 or 2 but not grade 3 * Patient practicing a non-contact pivot sport (sliding sports, board sports,racket) Exclusion Criteria: * Patient with contralateral ACL tear * Patient practicing a pivot sport with contacts * Patient presenting external rotary jumps ++ and +++ * Patient with an ACL tear Sherman 3 or 4 * Patient with meniscal lesions in the shape of a bucket handle or tabs unstable meniscals * Patient with a surgical history on the knee concerned

Primary outcome measure(s)

  • Subjective IKDC (International Knee Documentation Committee) score — 1 day
    Subjective IKDC score is based on 10 questions linded to knee status. This score is ranging from 0 to 100. 100 means a level of sport activity and daily activity without any limit in the absence of any symptoms.

Trial sites (1)

FacilityCityRegionStatus
Hôpital Privé La Louvière Lille Choisir Une Région Recruiting

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06178484 on ClinicalTrials.gov ↗ ← All trials in France